![Tuomas Tenkanen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tuomas Tenkanen
Director Ejecutivo en Mobidiag Oy .
Cargos activos de Tuomas Tenkanen
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Director/Miembro de la Junta | 01/01/2013 | - |
Director Ejecutivo | 01/01/2013 | - | |
TJT Technologies Oy
![]() TJT Technologies Oy BiotechnologyHealth Technology TJT Technologies Oy is a Finnish company that specializes in researching and developing biotechnology products. The private company is based in Helsinki, Finland. | Presidente | 01/01/2011 | - |
Historial de carrera de Tuomas Tenkanen
Antiguos cargos conocidos de Tuomas Tenkanen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AIFORIA TECHNOLOGIES OYJ | Director/Miembro de la Junta | 07/03/2013 | 01/01/2017 |
Finnzymes Oy
![]() Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Director Técnico/Científico/I+D | - | - |
Formación de Tuomas Tenkanen.
Aalto University School of Science & Technology | Undergraduate Degree |
Estadísticas
Internacional
Finlandia | 6 |
Operativa
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 3 |
Commercial Services | 2 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AIFORIA TECHNOLOGIES OYJ | Technology Services |
Empresas privadas | 3 |
---|---|
Finnzymes Oy
![]() Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Commercial Services |
TJT Technologies Oy
![]() TJT Technologies Oy BiotechnologyHealth Technology TJT Technologies Oy is a Finnish company that specializes in researching and developing biotechnology products. The private company is based in Helsinki, Finland. | Health Technology |
- Bolsa de valores
- Insiders
- Tuomas Tenkanen
- Experiencia